|
|
|
 |
TissueGene
has developed a proprietary genetic technology with applications in
the treatment and regeneration of damaged tendons, ligaments, cartilage
and bones. |
 |
TissueGene's collaborative
agreements across the globe make it possible to have a network of
investigators with ongoing research occuring 24 hours a day. |
|
|
 |
TissueGene is initially focusing
on providing a permanent cure for osteoarthritis (OA), a debilitating
condition that affects ~1 in 7 people with medical costs approaching
$16B/y in the US. |
 |
TissueGene
is borrowing on the lessons of the past, and is working to become
a leader in an industry which requires "out of the box"
thinking combined with solid teamwork. |
|
